A blocking enzyme-linked immunosorbent assay (B-ELISA), using two neutralizing monoclonal antibodies (MAbs), was established and compared with the virus neutralization test (VNT) for detecting specific peste-des-petits-ruminants virus (PPRV) antibody in caprine and ovine sera. This technique was developed because VNT, the only available specific serological test for PPRV and the cross-reactive rinderpest virus (RPV), is time-consuming and unaffordable for most laboratories in regions where both peste des petits ruminants and rinderpest occur. The test depends on the blocking of the binding of the MAb to a specific epitope in the presence of positive serum. Test conditions were optimized by using peste-des-petits-ruminants and rinderpest sera that were known to be VNT positive and negative. A blocking format, in which serum is preincubated with a solid-phase PPRV antigen and then incubated with the MAb, yielded levels of sensitivity and specificity superior to those of a competitive format, in which the two reagents are added simultaneously.
Peste des petits ruminants (PPR) is an acute or subacute viral disease of goats and sheep characterized by fever, erosive stomatitis, conjunctivitis, gastroenteritis, and pneumonia (25) . PPR virus (PPRV) is a paramyxovirus of the Morbillivirus genus that includes rinderpest virus (RPV), canine distemper virus (CDV), measles virus (MV), and phocid distemper virus (PDV) (11, 20, 21) . RPV is essentially a virus of cattle, but it also causes a disease syndrome in sheep and goats that is clinically indistinguishable from PPRV infection (25) .
Various techniques have been applied in the serological diagnosis of PPR in goats and sheep. These include the microplate virus neutralization test (VNT) (22) , agar gel precipitation (6, 7) , immunoelectroosmophoresis (15) , countercurrent immunoelectroosmophoresis (8) , and indirect enzyme-linked immunosorbent assay (ELISA) (18, 19) . There is a close antigenic relationship between PPRV and RPV (and indeed among all five morbilliviruses) which translates into serological cross-reactivity (11, 12, 17) . Serological tests done with polyclonal antibody may therefore be incapable of differentiating between serum antibody to PPRV and antibody to RPV. In recent years, the seroepidemiology of PPR has been further complicated by massive use of the heterologous rinderpest (RP) tissue culture-attenuated vaccine for PPR prophylaxis in several African countries (13) .
The VNT is currently the only available test that can distinguish between PPR and RPV serum antibodies (25) . Serum raised against either virus may neutralize both viruses but would neutralize the homologous virus at a higher titer than it would the heterologous virus (24, 26) . The VNT takes at least 7 days to reach an end point, is laborious, and requires a laboratory with cell culture facilities.
There is a need, therefore, for a rapid, reliable, and simple test that can discriminate PPRV antibody from antibody to the other morbilliviruses, particularly RPV. This paper reports on a blocking ELISA (B-ELISA) using two neutralizing monoclonal antibodies (MAbs), specific for the hemagglutinin protein of PPRV, for rapid detection and endpoint titration of PPRV antibody in sera. sheep, and one bovine) were compared (log2 VN1oo is the log2 of the reciprocal of the highest dilution that completely neutralized virus-specific cytopathic effect). First, the MAbs (hybridoma supernatant or ascitic fluid) were titrated by adding serial twofold dilutions to antigen-coated plates and running an indirect ELISA ( Fig. la and 2a) . Then, three dilutions of MAb were arbitrarily chosen, corresponding to 100, 75 to 80, and 50% of the plateau (saturation) OD on the titration curve, and tested by B-ELISA and competitive ELISA against serial twofold dilutions of the sera (Fig. lb,   2b , and 3). Finally, to establish the optimal incubation periods for serum and MAb, optimal dilutions of serum and MAb were tested while the relative incubation periods were varied (data not shown). All samples were tested in duplicate. Controls included wells with no serum (0% inhibition) and wells with no serum and no MAb (100% inhibition) (see below), the missing component being replaced with diluent (PBST).
Comparison of the VNT and B-ELISA for titration of sera. The assay for morbillivirus antibody in sera was done by the microplate virus neutralization method (18, 22) with Vero cells. Test viruses were PPRV Nigeria 75/1 attenuated, used after 1 passage in sheep kidney cells, 1 passage in bovine kidney cells, and 62 passages in Vero cells (5); RPV RBOK vaccine strain (98 passages in bovine kidney cells and 4 passages in Vero cells); CDV Onderstepoort strain (unknown passage history); MV Edmonston (unknown passage history); and PDV1-2-6A (unknown passage history). Serial twofold dilutions of serum samples were tested in duplicate against approximately 100 50% tissue culture infective doses of the appropriate virus(es). The VNT titer was determined after a 3-to 10-day incubation period (depending on the cytopathogenicity of the virus) and expressed as log2 VN100.
The B-ELISA was evaluated with field sera that were screened at the optimal dilution (1:20) and MAb B2G4 ascitic fluid. Assay for PPRV-specific antibody by the VNT and B-ELISA was also done with two sets of goat serum samples. One set (27 samples) came from nine goats that had been vaccinated with RPV and challenged with virulent PPRV Sudan 72/2, and the other (30 samples) came from six goats that had been vaccinated with attenuated PPRV Nigeria 75/1 (5) and challenged with virulent PPRV Sudan 72/2.
Serial twofold dilutions were added in duplicate to antigencoated plates, and B-ELISA was performed as described above. Titers were expressed as log2 of the reciprocal of the highest dilution of serum samples that gave a positive B-ELISA value.
Quantification of B-ELISA results and statistical analysis. The mean and standard deviation of percent inhibition values from PPRV-negative and -positive serum populations were calculated, and a negative cutoff was established. The correlation between the VNT and B-ELISA was assessed by determining the correlation coefficient (r) by using the Minitab statistical program. The relative specificity and sensitivity of B-ELISA were estimated by using the VNT as a standard test. Agreement between the two tests was also calculated by estimating the agreement quotient (kappa), following established procedures (16 Fig. lb , we adopted the 75 to 80% saturation dilution (1:300 and 1:20,000 final dilution, for supernatants and ascitic fluids, respectively) as the optimal dilution of the MAb in subsequent testing. At that concentration of the MAb, the optimal dilution for serum was the dilution yielding the peak P-N value. This serum dilution was 1:64 for hybridoma supernatants (Fig. lb) and 1:20 for ascitic fluid (Fig. 2b) . It is remarkable that the two MAbs plateaued at the same dilution with both hybridoma supernatants and ascitic fluids ( Fig. la and 2a) . In subsequent testing, we observed that they gave similar results in every test, and we chose to concentrate on B2G4 because of its greater availability.
Test format: competitive ELISA versus B-ELISA and incubation periods. We compared competition and blocking by titrating moderate-PPRV-positive sera (log2 VN1OO, 8 to 10) and PPRV-negative sera (Fig. 3) . This comparison was extended by evaluating the P-N values for different combinations of the serum and MAb incubation periods, with sera at the optimal dilution. Either serum and MAb were added simultaneously or MAb was added after preincubation with serum, for total incubation periods (serum plus MAb) of 90, 105, 120, and 135 min. Figure 3 clearly indicates that the blocking format yields a sensitivity superior to that of the competitive format, while having the same level of specificity. Furthermore, a 60-min preincubation with the serum and a further 60-min incubation after MAb was added resulted in optimal specificity and sensitivity.
Negative cutoff value. By using 131 serum samples negative for neutralizing activity against any of the morbilliviruses and 147 RPV-positive serum samples (Table 2) at the optimal 1:20 dilution (Fig. 2b) , a cutoff value was established for the B-ELISA (Fig. 4) . For the two populations combined (Fig.  4a) , the cutoff was arbitrarily set at the mean (14.5%) plus 2.7 standard deviations (1 standard deviation = 11.3%), or 45% inhibition. When the RPV-positive population is considered alone (Fig. 4c) , the same cutoff point is given by the mean plus 2.6 standard deviations. For the absolute-negative pop- ulation (Fig. 4b) , the mean plus 2.7 standard deviations gave a cutoff value of 18.7% inhibition.
Comparison of the VNT and B-ELISA. Figure 5 presents mean endpoint titers for the two sets of serum samples, as determined by the VNT and B-ELISA. The overall correlation coefficients between results of the two tests were 0.991 (n = 27) and 0.982 (n = 30) for the two sets of samples.
When 264 field serum samples were titrated by the VNT, an endpoint could not be determined for 11 (4.2%) that were either cytotoxic or contaminated. A total of 39 serum samples (14.8%) were positive by both the VNT and B-ELISA, 6 (2.3%) were negative by B-ELISA but positive by the VNT, and 208 (78.8%) were negative by both tests. Table 3 presents the calculation of agreement quotient based on the 253 samples that could be used in both tests. By combining all the samples, the specificity and sensitivity of B-ELISA relative to the VNT were estimated as shown in Table 4 . DISCUSSION PPR currently occurs in most African countries located between the Sahara and the equator (13, 25) , the Arabian peninsula (1, 10, 27) , the Middle East (13) , and India (23) . It exists in all countries where rinderpest occurs. Most laboratories in those areas cannot afford cell culture facilities that are indispensable for performing the VNT. Because of the immense economic importance of the two diseases, there is need for more affordable tools for differential diagnosis.
Our MAb-based blocking ELISA proved to be a rapid, sensitive, and specific method for detection of PPR antibody. The test offers the additional advantage, over indirect ELISA, of permitting screening of sera from different species with only one anti-immunoglobulin-horseradish peroxidase conjugate. (Table 2) . It is also noteworthy that the population of RP sera distinguished itself from absolute-negative sera by showing significantly higher mean percent inhibition values (P < 0.01), as determined by Student's t-test analysis. This could be due to steric hindrance caused by binding of nonspecific antibody to the numerous morbillivirus crossreactive epitopes present on the antigen. Unfortunately, our B-ELISA cannot be used to detect RPV antibody because of the overlap between RP-positive and absolute-negative populations (Fig. 4a) .
We standardized the B-ELISA to a microneutralization assay for two reasons: (i) the VNT is presently the only available test for differentiation of the PPRV and RPV antibodies, and (ii) neutralizing antibodies are considered the best predictor of host immune status. The B-ELISA results agreed very well with those of the VNT (Table 3) , and there was a very high positive correlation between the two test results (Fig. 5) . A similar, though slightly lower, correlation coefficient between the VNT and a competitive ELISA for specific detection of RPV antibody with nucleoproteinspecific MAbs was observed by Libeau et al. (14) . The higher correlation obtained in our test may be explained in part by our use of a more sensitive test format (Fig. 3) 
